The association between gabapentin and suicidality in bipolar patients

  title={The association between gabapentin and suicidality in bipolar patients},
  author={Wendy M. Leith and William E Lambert and James K. Boehnlein and Michael D Freeman},
  journal={International Clinical Psychopharmacology},
The aims of this study were to assess the association between gabapentin and suicidality in patients diagnosed with bipolar disorder (BD) and to determine whether the risk is greater relative to patients prescribed lithium. This retrospective observational study utilizes US population-based claims data assembled by PharMetrics Inc., comprising 47 918 patients diagnosed with BD. Patients were included if they were at least 18 years old and initiated a new monotherapy prescription of either… Expand
A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder
Overall, the studies show that gabapentin and its related drug pregabalin do not have significant clinical efficacy as either monotherapy or adjunctive therapy for bipolar disorder. Expand
A Comprehensive Review of the Evaluation, Diagnosis, and Treatment of Older Adult Bipolar Disorder
This review summarizes the extant literature on the epidemiology, neuropsychology, clinical assessment, and treatment/management of older adult bipolar disorder (OABD). The primary aim was to provideExpand
Differential Dorsolateral Prefrontal Cortex Proteomic Profiles of Suicide Victims with Mood Disorders
There is a reduction trend of KCNQ3 levels in the DLPFC of male suicide victims with mood disorders, a major public health concern; nevertheless, its neurobiology remains unknown. Expand
Anti-epileptic medications
This is a review of current literature published between January 2018 and December 2018 including any publications regarding antiepileptic agents, specifically focusing on the following medications. Expand


Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder.
Despite Food and Drug Administration reports regarding increased risk of suicidality associated with AED treatment, the current study reveals that, as a class, AEDs do not increase risk of suicide attempts in patients with bipolar disorder relative to patients not treated with an AED or lithium. Expand
Divalproex, lithium and suicide among Medicaid patients with bipolar disorder.
Lithium may have a protective effect with regard to suicide attempts among Medicaid patients with bipolar disorder and remains unclear whether or not lithium protects these patients against completed suicide. Expand
Research report Divalproex, lithium and suicide among Medicaid patients with bipolar disorder
Divalproex was the most common mood stabilizer (used by 33% of subjects) followed by gabapentin, lithium, and carbamazepine, and lithium treatment may be superior to divalProex therapy with regard to minimizing suicidal behavior among individuals with bipolar disorder. Expand
Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death.
The use of gabapentin, lamotrigine, oxcarbazepine, and tiagabine, compared with the use of topiramate, may be associated with an increased risk of suicidal acts or violent deaths. Expand
Antiepileptic Drugs and Suicide: A Systematic Review of Adverse Effects
There is no clear evidence of an association between the use of AEDs and an increased risk of suicide because of the heterogeneity in the studies at the clinical and methodological level. Expand
Psychotherapeutic intervention and suicide risk reduction in bipolar disorder: a review of the evidence.
The aim of this study was to systematically review the literature concerning the efficacy of psychosocial interventions in reducing the risk for attempting or committing suicide in bipolar patients. Expand
The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm?
It is recommended that all patients with epilepsy be routinely evaluated for depression, anxiety, and suicidality, and that future clinical trials include validated instruments to systematically assess these conditions to determine whether the possible signal observed by the FDA is real. Expand
Substance misuse of gabapentin.
Clinical experience suggests that gabapentin is now prevalent as a drug of abuse, and one of the recommended mainstays of evidence-based treatment. Expand
Gabapentin and suicide attempts
The purpose of this study was to determine if the antiepileptic drug gabapentin increases risk of suicide attempt in patients to which it was prescribed for various indications. Expand
Antiepileptic Drug Monotherapy Exposure and Suicide‐Related Behavior in Older Veterans
To examine the association between antiepileptic drug (AED) receipt and suicide‐related behavior (SRB) in older veterans, a large number of older veterans were surveyed. Expand